Ranitidine, commonly known by the brand name Zantac, was a widely used medication for reducing stomach acid. Its typical dosage varied depending on the condition being treated and the formulation. For adults, common dosages included 75 mg, 150 mg, and 300 mg. These were often prescribed for conditions such as peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome [1].
How was Ranitidine prescribed for different conditions?
For the treatment of duodenal ulcers and gastric ulcers, ranitidine was frequently prescribed at a dose of 150 mg twice daily [1]. To prevent ulcers from recurring, the dosage was often reduced to 150 mg once daily at bedtime [1]. In cases of GERD, a common regimen involved taking 150 mg twice daily, with a higher dose of 300 mg once daily at bedtime recommended for more severe cases or symptom relief [1]. For Zollinger-Ellison syndrome, a rare condition causing excessive stomach acid production, patients typically started with 150 mg three times daily, with doses potentially adjusted up to 6.3 mg per kilogram of body weight per day, divided into multiple doses [1].
What led to Ranitidine's withdrawal from the market?
In April 2020, the U.S. Food and Drug Administration (FDA) requested that all manufacturers withdraw ranitidine products from the market [1]. This action was taken after investigations revealed the presence of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, in ranitidine products [1]. Studies indicated that NDMA could form in ranitidine over time, particularly when stored at higher temperatures, and that the levels of NDMA increased as the drug aged [1]. Concerns about the potential health risks associated with long-term exposure to NDMA led to the widespread recall and discontinuation of ranitidine [1].
What are the alternatives to Ranitidine for stomach acid reduction?
Following the withdrawal of ranitidine, several alternative medications are available to manage conditions requiring stomach acid reduction. These include other H2 blockers, such as famotidine (Pepcid) and cimetidine (Tagamet), which work similarly by blocking histamine H2 receptors in the stomach to decrease acid production [2]. Proton pump inhibitors (PPIs) are another class of drugs that are highly effective at reducing stomach acid. Common PPIs include omeprazole (Prilosec), lansoprazole (Prevacid), esomeprazole (Nexium), and pantoprazole (Protonix) [3]. These medications work by irreversibly blocking the enzyme responsible for acid production in the stomach. Antacids are also available for immediate, short-term relief of heartburn and indigestion by neutralizing existing stomach acid [2].
What is NDMA and why is it a concern?
N-Nitrosodimethylamine (NDMA) is a chemical compound that is classified as a probable human carcinogen by the U.S. Environmental Protection Agency [4]. It can be found in some foods and water, and exposure can also occur through certain industrial processes [4]. Concerns about NDMA in pharmaceuticals stem from its potential to cause cancer with long-term exposure [1][4]. The detection of NDMA in ranitidine products raised significant public health concerns and prompted regulatory action to protect consumers [1].